乳がんプロファイリングは、予測期間中、がん／腫瘍プロファイリング市場において市場を席巻すると予測されています。この市場占有率は、乳がんの世界的な罹患率の上昇、広範なスクリーニングの取り組み、そして乳がん診断におけるゲノムプロファイリングとプロテオームプロファイリング技術の急速な統合に起因しています。バイオマーカーに基づくアッセイと標的治療の進歩により、腫瘍特異的なドライバーを特定するための包括的なプロファイリングの需要が高まっています。さらに、啓発活動の拡大、政府支援による早期発見プログラム、そして乳がん研究への資金提供の急増により、乳がんプロファイリングは、この分野において最大の収益を生み出すセグメントとしての地位を固めています。
技術別では、次世代シーケンシング（NGS）が引き続き市場収益の牽引役となっています。数百万のDNA断片を同時に解析できる能力は、腫瘍の異質性を解読する上で比類のない速度と精度を提供します。免疫アッセイやPCR法は、その手頃な価格とアクセスのしやすさから日常的なアプリケーションにおいて依然として重要な役割を果たしていますが、NGSは高度な腫瘍学研究や臨床試験において不可欠なものとなっています。さらに、この技術のコスト低下と、先進国および発展途上国の医療システムにおける導入増加が相まって、NGSの成長をさらに促進しています。NGSは収益面で市場を支配している一方で、免疫アッセイなどの補完技術は、コスト重視の環境で引き続き高い導入率を維持すると予想されています。
世界のがん／腫瘍プロファイリング市場調査の主要地域は、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、中東・アフリカです。北アメリカは、先進的な医療インフラ、がん罹患率の高さ、バイオテクノロジー企業による積極的な研究開発投資に支えられ、2025年には最大のシェアを占めると予測されています。主要市場プレーヤーの存在、有利な償還政策、そして先進的な診断プラットフォームの急速な導入は、この地域の優位性をさらに高めています。一方、アジア太平洋地域は、がん罹患率の上昇、精密医療への意識の高まり、そして中国やインドなどの国々における医療インフラの拡大に牽引され、最も急速に成長する地域になると予測されています。政府によるゲノム研究への支援、そして地域の病院と世界的なバイオテクノロジー企業との連携強化は、アジア太平洋地域全体で腫瘍プロファイリングの需要を加速させると予想されます。
本調査の目的は、近年における様々なセグメントおよび国における市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における業界の定性的および定量的側面の両方を網羅するように設計されており、市場の将来の成長を決定づける推進要因や課題といった重要な側面についても詳細な情報を提供しています。さらに、利害関係者が投資できるマイクロ市場における潜在的な機会、そして主要プレーヤーの競争環境と製品提供の詳細な分析も盛り込んでいます。
目次
Table of Contents
Chapter 1. Global Cancer/Tumor Profiling Market Report Scope & Methodology
1.1. Research Objective
1.2. Research Methodology
1.2.1. Forecast Model
1.2.2. Desk Research
1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
1.4.1. Market Definition
1.4.2. Market Segmentation
1.5. Research Assumption
1.5.1. Inclusion & Exclusion
1.5.2. Limitations
1.5.3. Years Considered for the Study
Chapter 2. Executive Summary
2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. key Findings
Chapter 3. Global Cancer/Tumor Profiling Market Forces Analysis
3.1. Market Forces Shaping The Global Cancer/Tumor Profiling Market (2024-2035)
3.2. Drivers
3.2.1. The rising prevalence of cancer worldwide
3.2.2. Growing adoption of precision medicine
3.3. Restraints
3.3.1. Limited infrastructure in underdeveloped regions
3.4. Opportunities
3.4.1. The integration of advanced bioinformatics platforms
Chapter 4. Global Spacer Fluid Industry Analysis
4.1. Porter’s 5 Forces Model
4.1.1. Bargaining Power of Buyer
4.1.2. Bargaining Power of Supplier
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion
Chapter 5. Global Cancer/Tumor Profiling Market Size & Forecasts by Cancer Type 2025-2035
5.1. Market Overview
5.2. Global Growth Hormone Deficiency Market Performance - Potential Analysis (2025)
5.3. Breast Cancer
5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.3.2. Market size analysis, by region, 2025-2035
5.4. Lung Cancer
5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.4.2. Market size analysis, by region, 2025-2035￥
5.5. Colorectal Cancer
5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.5.2. Market size analysis, by region, 2025-2035
5.6. Prostate Cancer
5.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.6.2. Market size analysis, by region, 2025-2035
5.7. Melanoma Cancer
5.7.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.7.2. Market size analysis, by region, 2025-2035
5.8. Other Cancer
5.8.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.8.2. Market size analysis, by region, 2025-2035
Chapter 6. Global Cancer/Tumor Profiling Market Size & Forecasts by Biomarker Type 2025-2035
6.1. Market Overview
6.2. Global Growth Hormone Deficiency Market Performance - Potential Analysis (2025)
6.3. Genomic Biomarker
6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.3.2. Market size analysis, by region, 2025-2035
6.4. Protein Biomarker
6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.4.2. Market size analysis, by region, 2025-2035
Chapter 7. Global Cancer/Tumor Profiling Market Size & Forecasts by Technology 2025-2035
7.1. Market Overview
7.2. Global Growth Hormone Deficiency Market Performance - Potential Analysis (2025)
7.3. Immunoassays
7.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
7.3.2. Market size analysis, by region, 2025-2035
7.4. Next-Generation Sequencing
7.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
7.4.2. Market size analysis, by region, 2025-2035
7.5. Polymerase Chain Reaction
7.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
7.5.2. Market size analysis, by region, 2025-2035
7.6. Mass Spectrometry
7.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
7.6.2. Market size analysis, by region, 2025-2035
7.7. In-Situ Hybridization
7.7.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
7.7.2. Market size analysis, by region, 2025-2035
7.8. Microarrays
7.8.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
7.8.2. Market size analysis, by region, 2025-2035
7.9. Others
7.9.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
7.9.2. Market size analysis, by region, 2025-2035
Chapter 8. Global Cancer/Tumor Profiling Market Size & Forecasts by Technique 2025-2035
8.1. Market Overview
8.2. Global Growth Hormone Deficiency Market Performance - Potential Analysis (2025)
8.3. Genomics
8.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
8.3.2. Market size analysis, by region, 2025-2035
8.4. Proteomics
8.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
8.4.2. Market size analysis, by region, 2025-2035
8.5. Metabolomics
8.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
8.5.2. Market size analysis, by region, 2025-2035
8.6. Epigentics
8.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
8.6.2. Market size analysis, by region, 2025-2035
Chapter 9. Global Cancer/Tumor Profiling Market Size & Forecasts by Technology 2025-2035
9.1. Market Overview
9.2. Global Growth Hormone Deficiency Market Performance - Potential Analysis (2025)
9.3. Research
9.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
9.3.2. Market size analysis, by region, 2025-2035
9.4. Biomarker Discovery
9.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
9.4.2. Market size analysis, by region, 2025-2035
9.5. Personalized Medicine
9.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
9.5.2. Market size analysis, by region, 2025-2035
9.6. Clinical Application
9.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
9.6.2. Market size analysis, by region, 2025-2035
9.7. Diagnostics
9.7.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
9.7.2. Market size analysis, by region, 2025-2035
9.8. Prognostics
9.8.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
9.8.2. Market size analysis, by region, 2025-2035
9.9. Screening
9.9.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
9.9.2. Market size analysis, by region, 2025-2035
9.10. Treatment
9.10.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
9.10.2. Market size analysis, by region, 2025-2035
9.11. Monitoring
9.11.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
9.11.2. Market size analysis, by region, 2025-2035
Chapter 10. Global Cancer/Tumor Profiling Market Size & Forecasts by Region 2025-2035
10.1. Growth Cancer/Tumor Profiling Market, Regional Market Snapshot
10.2. Top Leading & Emerging Countries
10.3. North America Cancer/Tumor Profiling Market
10.3.1. U.S. Cancer/Tumor Profiling Market
10.3.1.1. Cancer Type breakdown size & forecasts, 2025-2035
10.3.1.2. Biomarker Type breakdown size & forecasts, 2025-2035
10.3.1.3. Technology breakdown size & forecasts, 2025-2035
10.3.1.4. Technique breakdown size & forecasts, 2025-2035
10.3.1.5. Application breakdown size & forecasts, 2025-2035
10.3.2. Canada Cancer/Tumor Profiling Market
10.3.2.1. Cancer Type breakdown size & forecasts, 2025-2035
10.3.2.2. Biomarker Type breakdown size & forecasts, 2025-2035
10.3.2.3. Technology breakdown size & forecasts, 2025-2035
10.3.2.4. Technique breakdown size & forecasts, 2025-2035
10.3.2.5. Application breakdown size & forecasts, 2025-2035
10.4. Europe Cancer/Tumor Profiling Market
10.4.1. UK Cancer/Tumor Profiling Market
10.4.1.1. Cancer Type breakdown size & forecasts, 2025-2035
10.4.1.2. Biomarker Type breakdown size & forecasts, 2025-2035
10.4.1.3. Technology breakdown size & forecasts, 2025-2035
10.4.1.4. Technique breakdown size & forecasts, 2025-2035
10.4.1.5. Application breakdown size & forecasts, 2025-2035
10.4.2. Germany Cancer/Tumor Profiling Market
10.4.2.1. Cancer Type breakdown size & forecasts, 2025-2035
10.4.2.2. Biomarker Type breakdown size & forecasts, 2025-2035
10.4.2.3. Technology breakdown size & forecasts, 2025-2035
10.4.2.4. Technique breakdown size & forecasts, 2025-2035
10.4.2.5. Application breakdown size & forecasts, 2025-2035
10.4.3. France Cancer/Tumor Profiling Market
10.4.3.1. Cancer Type breakdown size & forecasts, 2025-2035
10.4.3.2. Biomarker Type breakdown size & forecasts, 2025-2035
10.4.3.3. Technology breakdown size & forecasts, 2025-2035
10.4.3.4. Technique breakdown size & forecasts, 2025-2035
10.4.3.5. Application breakdown size & forecasts, 2025-2035
10.4.4. Spain Cancer/Tumor Profiling Market
10.4.4.1. Cancer Type breakdown size & forecasts, 2025-2035
10.4.4.2. Biomarker Type breakdown size & forecasts, 2025-2035
10.4.4.3. Technology breakdown size & forecasts, 2025-2035
10.4.4.4. Technique breakdown size & forecasts, 2025-2035
10.4.4.5. Application breakdown size & forecasts, 2025-2035
10.4.5. Italy Cancer/Tumor Profiling Market
10.4.5.1. Cancer Type breakdown size & forecasts, 2025-2035
10.4.5.2. Biomarker Type breakdown size & forecasts, 2025-2035
10.4.5.3. Technology breakdown size & forecasts, 2025-2035
10.4.5.4. Technique breakdown size & forecasts, 2025-2035
10.4.5.5. Application breakdown size & forecasts, 2025-2035
10.4.6. Rest of Europe Cancer/Tumor Profiling Market
10.4.6.1. Cancer Type breakdown size & forecasts, 2025-2035
10.4.6.2. Biomarker Type breakdown size & forecasts, 2025-2035
10.4.6.3. Technology breakdown size & forecasts, 2025-2035
10.4.6.4. Technique breakdown size & forecasts, 2025-2035
10.4.6.5. Application breakdown size & forecasts, 2025-2035
10.5. Asia Pacific Cancer/Tumor Profiling Market
10.5.1. China Cancer/Tumor Profiling Market
10.5.1.1. Cancer Type breakdown size & forecasts, 2025-2035
10.5.1.2. Biomarker Type breakdown size & forecasts, 2025-2035
10.5.1.3. Technology breakdown size & forecasts, 2025-2035
10.5.1.4. Technique breakdown size & forecasts, 2025-2035
10.5.1.5. Application breakdown size & forecasts, 2025-2035
10.5.2. India Cancer/Tumor Profiling Market
10.5.2.1. Cancer Type breakdown size & forecasts, 2025-2035
10.5.2.2. Biomarker Type breakdown size & forecasts, 2025-2035
10.5.2.3. Technology breakdown size & forecasts, 2025-2035
10.5.2.4. Technique breakdown size & forecasts, 2025-2035
10.5.2.5. Application breakdown size & forecasts, 2025-2035
10.5.3. Japan Cancer/Tumor Profiling Market
10.5.3.1. Cancer Type breakdown size & forecasts, 2025-2035
10.5.3.2. Biomarker Type breakdown size & forecasts, 2025-2035
10.5.3.3. Technology breakdown size & forecasts, 2025-2035
10.5.3.4. Technique breakdown size & forecasts, 2025-2035
10.5.3.5. Application breakdown size & forecasts, 2025-2035
10.5.4. Australia Cancer/Tumor Profiling Market
10.5.4.1. Cancer Type breakdown size & forecasts, 2025-2035
10.5.4.2. Biomarker Type breakdown size & forecasts, 2025-2035
10.5.4.3. Technology breakdown size & forecasts, 2025-2035
10.5.4.4. Technique breakdown size & forecasts, 2025-2035
10.5.4.5. Application breakdown size & forecasts, 2025-2035
10.5.5. South Korea Cancer/Tumor Profiling Market
10.5.5.1. Cancer Type breakdown size & forecasts, 2025-2035
10.5.5.2. Biomarker Type breakdown size & forecasts, 2025-2035
10.5.5.3. Technology breakdown size & forecasts, 2025-2035
10.5.5.4. Technique breakdown size & forecasts, 2025-2035
10.5.5.5. Application breakdown size & forecasts, 2025-2035
10.5.6. Rest of APAC Cancer/Tumor Profiling Market
10.5.6.1. Cancer Type breakdown size & forecasts, 2025-2035
10.5.6.2. Biomarker Type breakdown size & forecasts, 2025-2035
10.5.6.3. Technology breakdown size & forecasts, 2025-2035
10.5.6.4. Technique breakdown size & forecasts, 2025-2035
10.5.6.5. Application breakdown size & forecasts, 2025-2035
10.6. Latin America Cancer/Tumor Profiling Market
10.6.1. Brazil Cancer/Tumor Profiling Market
10.6.1.1. Cancer Type breakdown size & forecasts, 2025-2035
10.6.1.2. Biomarker Type breakdown size & forecasts, 2025-2035
10.6.1.3. Technology breakdown size & forecasts, 2025-2035
10.6.1.4. Technique breakdown size & forecasts, 2025-2035
10.6.1.5. Application breakdown size & forecasts, 2025-2035
10.6.2. Mexico Cancer/Tumor Profiling Market
10.6.2.1. Cancer Type breakdown size & forecasts, 2025-2035
10.6.2.2. Biomarker Type breakdown size & forecasts, 2025-2035
10.6.2.3. Technology breakdown size & forecasts, 2025-2035
10.6.2.4. Technique breakdown size & forecasts, 2025-2035
10.6.2.5. Application breakdown size & forecasts, 2025-2035
10.7. Middle East and Africa Cancer/Tumor Profiling Market
10.7.1. UAE Cancer/Tumor Profiling Market
10.7.1.1. Cancer Type breakdown size & forecasts, 2025-2035
10.7.1.2. Biomarker Type breakdown size & forecasts, 2025-2035
10.7.1.3. Technology breakdown size & forecasts, 2025-2035
10.7.1.4. Technique breakdown size & forecasts, 2025-2035
10.7.1.5. Application breakdown size & forecasts, 2025-2035
10.7.2. Saudi Arabia (KSA) Cancer/Tumor Profiling Market
10.7.2.1. Cancer Type breakdown size & forecasts, 2025-2035
10.7.2.2. Biomarker Type breakdown size & forecasts, 2025-2035
10.7.2.3. Technology breakdown size & forecasts, 2025-2035
10.7.2.4. Technique breakdown size & forecasts, 2025-2035
10.7.2.5. Application breakdown size & forecasts, 2025-2035
10.7.3. South Africa Cancer/Tumor Profiling Market
10.7.3.1. Cancer Type breakdown size & forecasts, 2025-2035
10.7.3.2. Biomarker Type breakdown size & forecasts, 2025-2035
10.7.3.3. Technology breakdown size & forecasts, 2025-2035
10.7.3.4. Technique breakdown size & forecasts, 2025-2035
10.7.3.5. Application breakdown size & forecasts, 2025-2035
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Illumina, Inc.
11.2.1. Company Overview
11.2.2. Key Executives
11.2.3. Company Snapshot
11.2.4. Financial Performance (Subject to Data Availability)
11.2.5. Product/Services Port
11.2.6. Recent Development
11.2.7. Market Strategies
11.2.8. SWOT Analysis
11.3. F. Hoffmann-La Roche Ltd.
11.4. Thermo Fisher Scientific, Inc.
11.5. QIAGEN N.V.
11.6. Agilent Technologies, Inc.
11.7. PerkinElmer, Inc.
11.8. Guardant Health, Inc.
11.9. Exact Sciences Corporation
11.10. Caris Life Sciences
11.11. Nanostring Technologies, Inc.
11.12. NeoGenomics Laboratories, Inc.
11.13. HTG Molecular Diagnostics, Inc.
11.14. Foundation Medicine, Inc.
11.15. Genomic Health, Inc.
11.16. Eurofins Scientific
List of Tables
Table 1. Global Cancer/Tumor Profiling Market, Report Scope
Table 2. Global Cancer/Tumor Profiling Market Estimates & Forecasts By Region 2024-2035
Table 3. Global Cancer/Tumor Profiling Market Estimates & Forecasts By Segment 2024-2035
Table 4. Global Cancer/Tumor Profiling Market Estimates & Forecasts By Segment 2024-2035
Table 5. Global Cancer/Tumor Profiling Market Estimates & Forecasts By Segment 2024-2035
Table 6. Global Cancer/Tumor Profiling Market Estimates & Forecasts By Segment 2024-2035
Table 7. Global Cancer/Tumor Profiling Market Estimates & Forecasts By Segment 2024-2035
Table 8. U.S. Cancer/Tumor Profiling Market Estimates & Forecasts, 2024-2035
Table 9. Canada Cancer/Tumor Profiling Market Estimates & Forecasts, 2024-2035
Table 10. UK Cancer/Tumor Profiling Market Estimates & Forecasts, 2024-2035
Table 11. Germany Cancer/Tumor Profiling Market Estimates & Forecasts, 2024-2035
Table 12. France Cancer/Tumor Profiling Market Estimates & Forecasts, 2024-2035
Table 13. Spain Cancer/Tumor Profiling Market Estimates & Forecasts, 2024-2035
Table 14. Italy Cancer/Tumor Profiling Market Estimates & Forecasts, 2024-2035
Table 15. Rest Of Europe Cancer/Tumor Profiling Market Estimates & Forecasts, 2024-2035
Table 16. China Cancer/Tumor Profiling Market Estimates & Forecasts, 2024-2035
Table 17. India Cancer/Tumor Profiling Market Estimates & Forecasts, 2024-2035
Table 18. Japan Cancer/Tumor Profiling Market Estimates & Forecasts, 2024-2035
Table 19. Australia Cancer/Tumor Profiling Market Estimates & Forecasts, 2024-2035
Table 20. South Korea Cancer/Tumor Profiling Market Estimates & Forecasts, 2024-2035
………….
List of Figures
Fig 1. Global Cancer/Tumor Profiling Market, Research Methodology
Fig 2. Global Cancer/Tumor Profiling Market, Market Estimation Techniques
Fig 3. Global Market Size Estimates & Forecast Methods
Fig 4. Global Cancer/Tumor Profiling Market, Key Trends 2025
Fig 5. Global Cancer/Tumor Profiling Market, Growth Prospects 2024-2035
Fig 6. Global Cancer/Tumor Profiling Market, Porter’s Five Forces Model
Fig 7. Global Cancer/Tumor Profiling Market, Pestel Analysis
Fig 8. Global Cancer/Tumor Profiling Market, Value Chain Analysis
Fig 9. Cancer/Tumor Profiling Market By Application, 2025 & 2035
Fig 10. Cancer/Tumor Profiling Market By Segment, 2025 & 2035
Fig 11. Cancer/Tumor Profiling Market By Segment, 2025 & 2035
Fig 12. Cancer/Tumor Profiling Market By Segment, 2025 & 2035
Fig 13. Cancer/Tumor Profiling Market By Segment, 2025 & 2035
Fig 14. North America Cancer/Tumor Profiling Market, 2025 & 2035
Fig 15. Europe Cancer/Tumor Profiling Market, 2025 & 2035
Fig 16. Asia Pacific Cancer/Tumor Profiling Market, 2025 & 2035
Fig 17. Latin America Cancer/Tumor Profiling Market, 2025 & 2035
Fig 18. Middle East & Africa Cancer/Tumor Profiling Market, 2025 & 2035
Fig 19. Global Cancer/Tumor Profiling Market, Company Market Share Analysis (2025)
………….
